Israel Hereditary Angioedema Market (2025-2031) | Trends, Segmentation, Competitive Landscape, Analysis, Size & Revenue, Growth, Outlook, Industry, Share, Value, Companies, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 Israel Hereditary Angioedema Market - Industry Life Cycle

3.4 Israel Hereditary Angioedema Market - Porter's Five Forces

3.5 Israel Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Israel Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Israel Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about hereditary angioedema among healthcare professionals and patients

4.2.2 Advancements in diagnostic techniques and treatment options for hereditary angioedema

4.2.3 Rising prevalence of hereditary angioedema in Israel due to improved diagnosis and genetic testing

4.3 Market Restraints

4.3.1 High cost associated with hereditary angioedema treatments and therapies

4.3.2 Limited availability of specialized healthcare centers for hereditary angioedema patients in Israel

4.3.3 Lack of reimbursement policies for expensive hereditary angioedema treatments

6.1 Israel Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Israel Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Israel Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 Israel Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 Israel Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 Israel Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Israel Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 Israel Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 Israel Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 Israel Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Israel Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 Israel Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 Israel Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Hereditary Angioedema Market Export to Major Countries

7.2 Israel Hereditary Angioedema Market Imports from Major Countries

8.1 Average time to diagnosis for hereditary angioedema patients in Israel

8.2 Number of healthcare professionals trained in hereditary angioedema management

8.3 Percentage of hereditary angioedema patients receiving appropriate treatment and care

8.4 Patient adherence rate to prescribed hereditary angioedema therapies

9.1 Israel Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Israel Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Israel Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Israel Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 Israel Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters